v3.22.2.2
Stock Compensation Plan (Schedule Of Share Based Compensation Option And SARs Award Activity) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2020
Share-based Payment Arrangement [Abstract]      
Awards, outstanding beginning balance (in shares) 873 1,061 1,171
Awards, granted (in shares) 97 205 146
Awards, exercised (in shares) (278) (370) (247)
Awards, forfeited or expired (in shares) (13) (23) (9)
Awards, outstanding ending balance (in shares) 679 873 1,061
Awards, exercisable ending balance (in shares) 449    
Weighted-average exercise price, outstanding beginning balance (in dollars per share) $ 181.17 $ 138.59 $ 111.12
Weighted-average exercise price, granted (in dollars per share) 360.69 233.01 245.26
Weighted-average exercise price, exercised (in dollars per share) 93.32 84.20 67.19
Weighted-average exercise price, forfeited or expired (in dollars per share) 271.04 236.31 252.75
Weighted-average exercise price, outstanding ending balance (in dollars per share) 241.13 $ 181.17 $ 138.59
Weighted-average exercise price, exercisable ending balance (in dollars per share) $ 218.23    
Weighted-average remaining contractual term, outstanding ending balance (in years) 6 years 7 months 6 days    
Weighted-average remaining contractual term, exercisable ending balance (in years) 5 years 8 months 12 days    
Aggregate intrinsic value, outstanding ending balance $ 15,486,000,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 668    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $ 240.59    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 6 years 7 months 6 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $ 15,424,000,000    
Aggregate intrinsic value, exercisable ending balance $ 14,460,000,000